SensNews March 2020

Sensor100 Page 8 Together with Bosch Global Randox has developed a game-changing point of care coronavirus test. TheViral Respiratory Tract Infection Array can identify SARS-CoV-2 (COVID-19) and dif- ferentiate it from nine other respiratory infections with similar symptoms. Point of care coronavirus test from Ran- dox and Bosch will launch in April 2020 Dr. Heather McMillan, Molecular R&D Manager at Randox Biosciences, com- mented; “ This array focuses not only on the iden- tification of the novel coronavirus strain that causes COVID-19, but also nine other respiratory infection targets simultaneously, including Influenza A and B, Sarbecovirus and MERS.The aim is to diagnose patients fast and accurately from a single genetic sample, maximising containment of the virus whilst minimising the spread.With the development of this array onto a fully automated platform, patients can be diagnosed rapidly at point of care locations globally such as pharma- cies and doctor surgeries.” www.randox.com/bosch-coronavirus-vivalytic/ FIND OUT MORE

RkJQdWJsaXNoZXIy NDMyMTY=